Maryland 2025 Regular Session

Maryland Senate Bill SB940

Introduced
2/3/25  

Caption

Health Insurance and Family Planning Services – Consumer Protections – Updates

Summary

SB 940 updates Maryland health insurance and family planning statutes to align state law with federal rules and guidance as of December 31, 2024. The bill revises multiple cross-references in the Insurance Article and Health – General Article covering grandfathered plans, essential health benefits, summaries of benefits and coverage, medical loss ratios, hardship and affordability exemptions, annual cost-sharing limits, prescription drug coverage, and rescissions. It also updates references tied to the Family Planning Program and Maryland Medical Assistance Program. The bill expands and modernizes the definition of “family planning providers” and “family planning services” by updating the federal date reference and clarifying that providers may qualify even if they lost Title X funding because of the scope of services, referrals, counseling, or related funding/grant provisions. It also authorizes the Maryland Insurance Commissioner to adopt regulations needed to implement the discrimination-related insurance provisions and gives the Commissioner and the Commission on Civil Rights concurrent enforcement jurisdiction over those provisions.

Impact

SB 940 would amend the Maryland Code to keep state health insurance and family planning provisions synchronized with current federal law and regulatory guidance. In practice, it would affect the Department of Health, the Maryland Insurance Administration, the Maryland Health Benefit Exchange, family planning providers, insurers, and Medicaid-related family planning access rules. The bill does not create a new program, but it changes statutory definitions, enforcement authority, and regulatory authority that govern how existing consumer protection and family planning requirements are administered.

Sentiment

No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or opposition in the available materials. Based on the bill text, the measure appears largely technical and administrative, aimed at updating outdated federal references and preserving continuity in coverage and services. The overall tone of the legislation is policy-maintenance rather than major substantive reform.

Contention

The main potential points of contention are the family planning provisions and the enforcement changes. The bill preserves access for providers that lost Title X funding due to the scope of services or referrals, which could draw support from reproductive health advocates but opposition from groups concerned about the types of services offered by those providers. Another possible issue is the expansion of concurrent jurisdiction between the Insurance Commissioner and the Commission on Civil Rights for enforcing discrimination-related insurance provisions, which may raise questions about regulatory overlap, enforcement scope, and administrative discretion. The authorization for the Commissioner to adopt implementing regulations could also be scrutinized by insurers or regulated entities seeking clearer limits.

Companion Bills

MD HB1045

Crossfiled Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

Similar Bills

No similar bills found.